Cargando…
m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer
N6-methyladenosine (m6A) is the most common form of messenger RNA (mRNA) modification. An increasing number of studies have proven that m6A RNA methylation regulators are overexpressed in many cancers and participate in the development of cancer through the dynamic regulation of m6A RNA methylation...
Autores principales: | Chen, Mei, Nie, Zhen-yu, Wen, Xiao-hong, Gao, Yuan-hui, Cao, Hui, Zhang, Shu-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923333/ https://www.ncbi.nlm.nih.gov/pubmed/31808521 http://dx.doi.org/10.1042/BSR20192892 |
Ejemplares similares
-
Prognostic value of CLIC3 mRNA overexpression in bladder cancer
por: Chen, Mei, et al.
Publicado: (2020) -
A new m(6)A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder
por: Zheng, Bin, et al.
Publicado: (2021) -
An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021) -
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019) -
Hub gene associated with prognosis in bladder cancer is a novel therapeutic target
por: Fang, Dengpan, et al.
Publicado: (2023)